← Back to Search

Other

Blood Flow Restriction + Myofascial Release for Muscle Strengthening

N/A

Waitlist Available

Research Sponsored by University of Tennessee

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial looks at how using blood flow restriction and myofascial release with whey protein helps strengthen muscles in the upper body.

Who is the study for?

This trial is for healthy individuals aged 18 to 30 who have no active infections, cancer diagnosis, history of deep vein thrombosis or sickle cell anemia. Pregnant individuals or those with recent severe upper extremity injuries, abnormal range of motion or muscle strength, uncontrolled high blood pressure, or diabetes cannot participate.Check my eligibility

What is being tested?

The study aims to measure the increase in muscle strength in the nondominant arm's proximal muscles by using techniques like blood flow restriction and myofascial release while also taking whey protein supplements.See study design

What are the potential side effects?

Potential side effects may include discomfort at the site of blood flow restriction, bruising from myofascial release therapy, and possible digestive issues related to whey protein intake.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Scapular retraction strength

Secondary outcome measures

One repetition maximum (1RM)

Other outcome measures

Length for the pectoralis minor

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Myofascial ReleaseExperimental Treatment2 Interventions

The Experimental group will receive a myofascial release pectoralis minor release intervention.

Group II: Sham Myofascial ReleasePlacebo Group2 Interventions

The Control group will receive a sham myofascial release pectoralis minor release intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

blood flow restriction

2020

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of TennesseeLead Sponsor

188 Previous Clinical Trials

141,581 Total Patients Enrolled

University of Tennessee Health Science CenterLead Sponsor

48 Previous Clinical Trials

25,044 Total Patients Enrolled

Media Library

Blood Flow Restriction and Myofascial Release (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05710757 — N/A

Proximal Muscle Strength Research Study Groups: Myofascial Release, Sham Myofascial Release

Proximal Muscle Strength Clinical Trial 2023: Blood Flow Restriction and Myofascial Release Highlights & Side Effects. Trial Name: NCT05710757 — N/A

Blood Flow Restriction and Myofascial Release (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05710757 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the study cohort limited to adults aged 40 and over?

"The prerequisites for this clinical trial state that the age range of participants must be between 18 and 30 years old."

Answered by AI

Would I be able to become an enrollee in this medical study?

"This study is searching for 60 volunteers, aged between 18 and 30 years old, that possess proximal muscle strength. A noteworthy criterion of the trial necessitates participants to be in good health within this age range."

Answered by AI

Are any additional participants being accepted at this juncture?

"According to the information provided on clinicaltrials.gov, this medical trial is no longer seeking participants as it was last updated on January 24th 2023. However, there are currently 1 other trials recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening

LaToya Green 2023. "Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05710757.